XM tillhandahåller inte tjänster till personer bosatta i USA.
G
G

Gerresheimer


Nyheter

Adidas, Spirax Group, Stroeer

EUROPE RESEARCH ROUNDUP-Adidas, Spirax Group, Stroeer July 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adidas, Spirax Group and Stroeer, on Wednesday. HIGHLIGHTS * Adidas AG ADSGn.DE : JP Morgan raises target price to EUR 260 from EUR 250 * J D Wetherspoon JDW.L : Jefferies raises target price to 1,000p from 925p * Spirax Group SPX.L : HSBC raises to hold from reduce * Stroeer SAXG.DE : HSBC raises target price to EUR 79 fro
A
A
A
A
A
B
B
C
D
D
E
E
E
F
F
G
R
S
S
U
A
A
E
E
R
S
U

Hargreaves Lansdown, Spectris, Wizz Air

EUROPE RESEARCH ROUNDUP-Hargreaves Lansdown, Spectris, Wizz Air July 12 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Hargreaves Lansdown, Spectris and Wizz Air, on Friday. HIGHLIGHTS * Hargreaves Lansdown HRGV.L : JP Morgan raises target price to 684p from 671p * Spectris Plc SXS.L : Jefferies cuts target price to 4190p from 4435p * Spirax-Sarco SPX.L : Jefferies cuts target price to 9580p from 9690p * Weir Group WEIR.L : Jefferi
A
A
B
B
B
C
C
D
E
E
E
E
E
G
H
H
I
L
L
M
R
R
S
S
W
A
D

Gerresheimer Exec On Conference Call - Estimate Revenue Growth To Be Around Lower End Of Our Guidance Range For 2024

BRIEF-Gerresheimer Exec On Conference Call - Estimate Revenue Growth To Be Around Lower End Of Our Guidance Range For 2024 July 11 (Reuters) - GERRESHEIMER AG GXIG.DE : EXEC ON CONFERENCE CALL - ESTIMATE REVENUE GROWTH TO BE AROUND LOWER END OF OUR GUIDANCE RANGE FOR 2024 Further company coverage: GXIG.DE (Gdansk Newsroom)
G

Gerresheimer up as guidance confirmation reassures, analysts say

BUZZ-Gerresheimer up as guidance confirmation reassures, analysts say ** Shares in Gerresheimer GXIG.DE rise around 2% in early Frankfurt trade after the German medical packaging devices maker reported a small earnings beat and stuck to its FY guidance ** "Good enough," J.P.Morgan says on the Q2 results, pointing to adjusted EBITDA coming in 2.5% a
G

Gerresheimer's weight-loss drug deals pipeline helps profits meet forecasts

UPDATE 2-Gerresheimer's weight-loss drug deals pipeline helps profits meet forecasts Adds guidance in paragraph 4, CEO comment in paragraph 3-5, analyst comment in paragraph 6 By Isabel Demetz July 11 (Reuters) - Medical equipment group Gerresheimer GXIG.DE posted second-quarter adjusted core profit in line with expectations on Thursday, driven by the deal pipeline for its plastics and devices business, which supplies weight-loss drug makers with autoinjector pens.
G

Gerresheimer's second-quarter results in line with expectations

Gerresheimer's second-quarter results in line with expectations July 11 (Reuters) - German packaging and medical equipment maker Gerresheimer GXIG.DE reported second-quarter core profit in line with market expectations on Thursday. Negative destocking effects in its primary packaging glass division were offset by the good performance of its plastics and devices division, it said.
G

Gerresheimer confirms 2024 guidance

BRIEF-Gerresheimer confirms 2024 guidance July 11 (Reuters) - Gerresheimer AG GXIG.DE : GERRESHEIMER AG - GERRESHEIMER REMAINS ON TRACK IN 1ST HALF YEAR 2024 GERRESHEIMER AG - ORGANIC GROWTH: REVENUES +1.7%, ADJUSTED EBITDA +2.9% GERRESHEIMER AG - PLASTICS & DEVICES DIVISION WITH GOOD REVENUE GROWTH AND SIGNIFICANTLY IMPROVED MARGIN GERRESHEIMER AG
G

Europe's STOXX 600 corporate earnings week ahead

DIARY-Europe's STOXX 600 corporate earnings week ahead July 5 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 08-Jul-2024 NTS INDUa.ST Industrivarden AB Q2 2024 Industrivarden AB Earnings Release 08-Jul-2024 05:30 WIHL.ST Wihlborgs Fastigheter AB Q2 2024 Wihlborgs Fastigheter AB Earnings Release 09-Jul-2024 06:00 KINVb.ST Kinnevik AB Q2 2024 Kinnevik AB Earnings Release 10-J
E
E
G
I
K
S

Obesity drug injections maker Gerresheimer expands capacity in US

Obesity drug injections maker Gerresheimer expands capacity in US May 27 (Reuters) - German drug vial maker Gerresheimer GXIG.DE on Monday announced an expansion of its U.S. production site as it sees growing demand for weight-loss drugs, including of the GLP-1 class. The company is investing around 166 million euros ($180.24 million) in the construction of two buildings, creating 400 new jobs in Peachtree.
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Thyssenkrupp, Hg, Hess Corp, Millicom International Cellular May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: * * Thyssenkrupp TKAG.DE said its supervisory board approved a planned sale of 20% of the conglomerate's steel division to Czech billionaire Daniel Kretinsky in the face of continued opposition from labour representatives.
C
G
H
T
A

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Updates: May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Nationwide Building Society NBS.L said it could realise as much as a 1.5 billion pound ($1.91 billion) gain on its acquisition of rival Virgin Money, announced earlier this year and expected to close in the fourth quarter.
G
H
A

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Thursday: ** Nationwide Building Society NBS.L said it could realise as much as a 1.5 billion pound ($1.91 billion) gain on its acquisition of rival Virgin Money, announced earlier this year and expected to close in the fourth quarter.
G
H
A

Gerresheimer shares shine on deal to buy Blitz LuxCo Sarl

BUZZ-Gerresheimer shares shine on deal to buy Blitz LuxCo Sarl ** Shares in Gerresheimer GXIG.DE jump 12.1% after the German medical equipment maker said it had signed a purchase agreement to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group for 800 million euros ($865.92 million) ** The transaction will be financed by a consortium of banks consisting of UniCredit, Commerzbank CBKG.DE and LBBW and is expected to close in Q4, according to the statement ** "We expect the m
C
G
U

Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln

UPDATE 1-Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln Adds details in paragraphs 2 and 3 and background in 4 and 5 May 23 (Reuters) - German packaging and medical equipment maker Gerresheimer GXIG.DE said on Thursday it signed a purchase agreement for acquiring Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group, for an enterprise value of 800 million euros ($866.32 million).
C
G
U

Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln

Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln May 23 (Reuters) - German packaging and medical equipment maker Gerresheimer GXIG.DE said on Thursday it signed a purchase agreement for acquiring Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group, for an enterprise value of 800 million euros ($866.32 million). ($1 = 0.9234
G

Gerresheimer Says To Acquire Blitz Luxco Sarl, The Holding Company Of The Bormioli Pharma Group

BRIEF-Gerresheimer Says To Acquire Blitz Luxco Sarl, The Holding Company Of The Bormioli Pharma Group May 23 (Reuters) - Gerresheimer AG GXIG.DE : EQS-ADHOC: GERRESHEIMER TO ACQUIRE BLITZ LUXCO SARL, THE HOLDING COMPANY OF THE BORMIOLI PHARMA GROUP / MOULDED GLASS BUSINESS TO BE STRATEGICALLY REVIEWED PURCHASE PRICE IS BASED ON A DETERMINED ENTERPR
G



Villkor

Populära tillgångar

Ansvarsfriskrivning: XM Group-enheter tillhandahåller sin tjänst enbart för exekvering och tillgången till vår onlinehandelsplattform, som innebär att en person kan se och/eller använda tillgängligt innehåll på eller via webbplatsen, påverkar eller utökar inte detta, vilket inte heller varit avsikten. Denna tillgång och användning omfattas alltid av i) villkor, ii) riskvarningar och iii) fullständig ansvarsfriskrivning. Detta innehåll tillhandahålls därför uteslutande som allmän information. Var framför allt medveten om att innehållet på vår onlinehandelsplattform varken utgör en uppmaning eller ett erbjudande om att ingå några transaktioner på de finansiella marknaderna. Handel på alla finansiella marknader involverar en betydande risk för ditt kapital.

Allt material som publiceras på denna sida är enbart avsett för utbildnings- eller informationssyften och innehåller inte – och ska inte heller anses innehålla – rådgivning och rekommendationer om finansiella frågor, investeringsskatt eller handel, dokumentation av våra handelskurser eller ett erbjudande om, eller en uppmaning till, en transaktion i finansiella instrument eller oönskade finansiella erbjudanden som är riktade till dig.

Tredjepartsinnehåll, liksom innehåll framtaget av XM såsom synpunkter, nyheter, forskningsrön, analyser, kurser, andra uppgifter eller länkar till tredjepartssajter som återfinns på denna webbplats, tillhandahålls i befintligt skick, som allmän marknadskommentar, och utgör ingen investeringsrådgivning. I den mån som något innehåll tolkas som investeringsforskning måste det noteras och accepteras att innehållet varken har varit avsett som oberoende investeringsforskning eller har utarbetats i enlighet med de rättsliga kraven för att främja ett sådant syfte, och därför är att betrakta som marknadskommunikation enligt tillämpliga lagar och föreskrifter. Se till så att du har läst och förstått vårt meddelande om icke-oberoende investeringsforskning och riskvarning om ovannämnda information, som finns här.

Riskvarning: Ditt kapital riskeras. Hävstångsprodukter passar kanske inte alla. Se vår riskinformation.